Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.9.3.1 (
cytochrome oxidase
)
8,822
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
To elucidate the potential role of mitochondria in
Taxol
-induced cytotoxicity, we studied its direct mitochondrial effects. In Percoll-gradient purified liver mitochondria,
Taxol
induced large amplitude swelling in a concentration-dependent manner in the microM range. Opening of the permeability pore was also confirmed by the access of mitochondrial matrix enzymes for membrane impermeable substrates in
Taxol
-treated mitochondria.
Taxol
induced the dissipation of mitochondrial membrane potential (DeltaPsi) determined by Rhodamine123 release and induced the release of cytochrome c from the intermembrane space. All these effects were inhibited by 2.5 microM cyclosporine A.
Taxol
significantly increased the formation of reactive oxygen species (ROS) in both the aqueous and the lipid phase as determined by dihydrorhodamine123 and resorufin derivative. Cytochrome oxidase inhibitor CN(-), azide, and NO abrogated the
Taxol
-induced mitochondrial ROS formation while inhibitors of the other respiratory complexes and cyclosporine A had no effect. We confirmed that the
Taxol
-induced collapse of DeltaPsi and the induction of ROS production occurs in BRL-3A cells. In conclusion,
Taxol
-induced adenine nucleotide translocase-cyclophilin complex mediated permeability transition, and
cytochrome oxidase
mediated ROS production. Because both cytochrome c release and mitochondrial ROS production can induce suicide pathways, the direct mitochondrial effects of
Taxol
may contribute to its cytotoxicity.
...
PMID:Direct effect of Taxol on free radical formation and mitochondrial permeability transition. 1149 88